Europe single cell multiomics market was valued at $ 527.9 million in 2021 and will grow by 18.0% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. Highlighted with 39 tables and 77 figures, this 150-page repo...
Asia Pacific single cell multiomics market will grow by 21.8% annually with a total addressable market cap of $ 16,032.0 million over 2022-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. Highlighted with 36 tables and 76 figur...
Global Pharmaceutical Analytical Testing Outsourcing Market will reach $16,527.5 million by 2031, growing by 8.4% annually over 2021-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 83 tables and 83 figures, this 164-page...
North America Pharmaceutical Analytical Testing Outsourcing Market is projected to grow by 7.5% annually in the forecast period and reach $ 6,029.2 million by 2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 24 tables and...
Europe Pharmaceutical Analytical Testing Outsourcing Market was valued at $1,919.1 million in 2021 and will grow by 8.4% annually over 2021-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 34 tables and 51 figures, this 1...
Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market will grow by 10.2% annually with a total addressable market cap of $30,233.3 million over 2022-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 31 tables a...
Global radiofrequency-based devices market will reach $12,158.3 million by 2031, growing by 12.5% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, an increasing focus on enhancing physical appearance, a rising preference for minimally invasive and non-invasive procedures, and technological advancements supported by the rising R&D investment in healthcare domain. Highlighted with 82 tables and 78 figures, this 163...
North America radiofrequency-based devices market is projected to grow by 11.0% annually in the forecast period and reach $4,328.3 million by 2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, an increasing focus on enhancing physical appearance, a rising preference for minimally invasive and non-invasive procedures, and technological advancements supported by the rising R&D investment in healthcare domain. Highlighted with 22 tables...
Europe radiofrequency-based devices market was valued at $985.3 million in 2021 and will grow by 12.6% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, an increasing focus on enhancing physical appearance, a rising preference for minimally invasive and non-invasive procedures, and technological advancements supported by the rising R&D investment in healthcare domain. Highlighted with 32 tables and 46 figures, thi...
Asia Pacific radiofrequency-based devices market will grow by 14.9% annually with a total addressable market cap of $ 17,513.8 million over 2022-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, an increasing focus on enhancing physical appearance, a rising preference for minimally invasive and non-invasive procedures, and technological advancements supported by the rising R&D investment in healthcare domain. Highlighted with 29 tab...
